A Texas father and son are both back home and getting to spend Christmas together after they were hospitalized recently.
Heart doctors are capturing images showing the inside of heart arteries, helping them watch plaque respond to powerful cholesterol drugs in real-time. In these studies, PCSK9 inhibitors, drugs that ...
Cleerly, a leader in AI-based cardiovascular imaging, presented a late-breaking analysis of registry data, Prognostic Value of AI-based Quantitative Coronary CT Evaluation Versus Standard Qualitative ...
A randomized trial laid the groundwork for FFRangio, a proprietary angiography-derived fractional flow reserve (FFR) tool, as a potential gatekeeper for coronary revascularization. When put to the ...
Coronary heart disease (CHD) is a leading cause of death worldwide, with millions of individuals affected annually. Traditional diagnostic methods, such as electrocardiograms (ECGs), are often ...
We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Katie Okamoto Katie Okamoto ...
WASHINGTON, Oct. 27, 2024 /PRNewswire/ -- Today at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) conference taking place at the Walter E. Washington ...
Abstract: The rise in stable coronary artery disease (CAD) due to improved survival rates and population growth has increased patient numbers, straining healthcare systems. Machine learning (ML) ...
HeartFlow announced today that the American Medical Association (AMA) transitioned reimbursement codes for its coronary artery disease assessment. The AMA changed the non-invasive, AI-based FFR CT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback